Pemphigus foliaceus worsened by drugs in a patient with psoriasis, responding to adalimumab.

Abstract	Pemphigus foliaceus is a blistering autoimmune disease related to the production of autoantibodies against desmoglein 1. We present a patient with psoriasis and pemphigus foliaceus aggravated by enalapril and amlodipine intake, with successful response of both conditions to adalimumab therapy.
Authors	Jimena Sanz-Bueno, Elena Gallo, Dolores Caro-Gutiérrez, Araceli Sánchez-Gilo, Marta Gutiérrez Pascual, Laura Rojas-Scheffer, Francisco Javier Vicente-Martín
Journal	Dermatology online journal (Dermatol Online J) Vol. 23 Issue 10 (10 15 2017) ISSN: 1087-2108 [Electronic] United States
PMID	29469785 (Publication Type: Case Reports, Journal Article)
Chemical References	Anti-Inflammatory Agents Antihypertensive Agents Amlodipine Enalapril Adalimumab
Topics	Adalimumab (therapeutic use) Amlodipine (adverse effects) Anti-Inflammatory Agents (therapeutic use) Antihypertensive Agents (adverse effects) Enalapril (adverse effects) Humans Male Middle Aged Pemphigus (chemically induced, drug therapy, pathology) Psoriasis (chemically induced, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!